128 related articles for article (PubMed ID: 16886687)
41. Cardiovascular disease in chronic kidney failure: the role of VDR activators.
Wu-Wong JR; Tian J; Nakane M; Ma J; Fey TA; Kroeger P; Fryer RM; Reinhart GA
Curr Opin Investig Drugs; 2006 Mar; 7(3):206-13. PubMed ID: 16555680
[TBL] [Abstract][Full Text] [Related]
42. [Long-term action of vitamin D suppresses the estradiol-induced activity of erk-1 MAPK and proliferation of MCF-7 and LNCaP cancer cells].
Liakhovich AV; Aksenov NL; Tuokhima P; Mikhel'son VM
Tsitologiia; 2000; 42(10):977-82. PubMed ID: 11200137
[TBL] [Abstract][Full Text] [Related]
43. Combination of 1alpha,25-dihydroxyvitamin D(3) with dexamethasone enhances cell cycle arrest and apoptosis: role of nuclear receptor cross-talk and Erk/Akt signaling.
Bernardi RJ; Trump DL; Yu WD; McGuire TF; Hershberger PA; Johnson CS
Clin Cancer Res; 2001 Dec; 7(12):4164-73. PubMed ID: 11751517
[TBL] [Abstract][Full Text] [Related]
44. Influence of calcitriol on prostaglandin- and vitamin D-metabolising enzymes in benign and malignant breast cell lines.
Thill M; Cordes T; Hoellen F; Becker S; Dittmer C; Kümmel S; Salehin D; Friedrich M; Diedrich K; Köster F
Anticancer Res; 2012 Jan; 32(1):359-65. PubMed ID: 22213327
[TBL] [Abstract][Full Text] [Related]
45. Epigenetic corruption of VDR signalling in malignancy.
Abedin SA; Banwell CM; Colston KW; Carlberg C; Campbell MJ
Anticancer Res; 2006; 26(4A):2557-66. PubMed ID: 16886664
[TBL] [Abstract][Full Text] [Related]
46. 1,24(S)-dihydroxyvitamin D2, an endogenous vitamin D2 metabolite, inhibits growth of breast cancer cells and tumors.
Zinser GM; Tribble E; Valrance M; Urben CM; Knutson JC; Mazess RB; Strugnell SA; Welsh J
Anticancer Res; 2005; 25(1A):235-41. PubMed ID: 15816543
[TBL] [Abstract][Full Text] [Related]
47. p38 MAPK signaling pathway is involved in butyrate-induced vitamin D receptor expression.
Daniel C; Schröder O; Zahn N; Gaschott T; Stein J
Biochem Biophys Res Commun; 2004 Nov; 324(4):1220-6. PubMed ID: 15504345
[TBL] [Abstract][Full Text] [Related]
48. Role of VDR in 1α,25-dihydroxyvitamin D3-dependent non-genomic activation of MAPKs, Src and Akt in skeletal muscle cells.
Buitrago C; Pardo VG; Boland R
J Steroid Biochem Mol Biol; 2013 Jul; 136():125-30. PubMed ID: 23470620
[TBL] [Abstract][Full Text] [Related]
49. Expression of 1,25-dihydroxyvitamin D(3) receptor in the immune system.
Veldman CM; Cantorna MT; DeLuca HF
Arch Biochem Biophys; 2000 Feb; 374(2):334-8. PubMed ID: 10666315
[TBL] [Abstract][Full Text] [Related]
50. Correlation between VDR expression and antiproliferative activity of vitamin D3 compounds in combination with cytostatics.
Pelczynska M; Wietrzyk J; Jaroszewicz I; Nevozhay D; Switalska M; Kutner A; Zabel M; Opolski A
Anticancer Res; 2005; 25(3B):2235-40. PubMed ID: 16158969
[TBL] [Abstract][Full Text] [Related]
51. Constitutive activation of the mitogen-activated protein kinase pathway impairs vitamin D signaling in human prostate epithelial cells.
Zhang Z; Kovalenko P; Cui M; Desmet M; Clinton SK; Fleet JC
J Cell Physiol; 2010 Aug; 224(2):433-42. PubMed ID: 20432439
[TBL] [Abstract][Full Text] [Related]
52. Vitamin D compounds: activity against microbes and cancer.
Gombart AF; Luong QT; Koeffler HP
Anticancer Res; 2006; 26(4A):2531-42. PubMed ID: 16886661
[TBL] [Abstract][Full Text] [Related]
53. Modulation of vitamin D receptor and estrogen receptor by 1,25(OH)2-vitamin D3 in T-47D human breast cancer cells.
Davoodi F; Brenner RV; Evans SR; Schumaker LM; Shabahang M; Nauta RJ; Buras RR
J Steroid Biochem Mol Biol; 1995 Aug; 54(3-4):147-53. PubMed ID: 7662588
[TBL] [Abstract][Full Text] [Related]
54. Cross-talk of vitamin D and glucocorticoids in hippocampal cells.
Obradovic D; Gronemeyer H; Lutz B; Rein T
J Neurochem; 2006 Jan; 96(2):500-9. PubMed ID: 16336217
[TBL] [Abstract][Full Text] [Related]
55. Effects of calcitriol, seocalcitol, and medium-chain triglyceride on a canine transitional cell carcinoma cell line.
Kaewsakhorn T; Kisseberth WC; Capen CC; Hayes KA; Calverley MJ; Inpanbutr N
Anticancer Res; 2005; 25(4):2689-96. PubMed ID: 16080513
[TBL] [Abstract][Full Text] [Related]
56. Vitamin D receptor is not essential for extracellular signal-related kinase phosphorylation by vitamin D(3) in human Caco-2/TC7 cells.
Yamauchi J; Sekiguchi M; Shirai T; Ishimi Y
Biosci Biotechnol Biochem; 2012; 76(8):1588-90. PubMed ID: 22878203
[TBL] [Abstract][Full Text] [Related]
57. Cdx2 polymorphism affects the activities of vitamin D receptor in human breast cancer cell lines and human breast carcinomas.
Pulito C; Terrenato I; Di Benedetto A; Korita E; Goeman F; Sacconi A; Biagioni F; Blandino G; Strano S; Muti P; Mottolese M; Falvo E
PLoS One; 2015; 10(4):e0124894. PubMed ID: 25849303
[TBL] [Abstract][Full Text] [Related]
58. The antitumor efficacy of calcitriol: preclinical studies.
Johnson CS; Muindi JR; Hershberger PA; Trump DL
Anticancer Res; 2006; 26(4A):2543-9. PubMed ID: 16886662
[TBL] [Abstract][Full Text] [Related]
59. Vitamin D receptors in breast cancer cells.
Buras RR; Schumaker LM; Davoodi F; Brenner RV; Shabahang M; Nauta RJ; Evans SR
Breast Cancer Res Treat; 1994; 31(2-3):191-202. PubMed ID: 7881099
[TBL] [Abstract][Full Text] [Related]
60. Sensitivity to growth suppression by 1alpha,25-dihydroxyvitamin D(3) among MCF-7 clones correlates with Vitamin D receptor protein induction.
Jensen SS; Madsen MW; Lukas J; Bartek J; Binderup L
J Steroid Biochem Mol Biol; 2002 Jun; 81(2):123-33. PubMed ID: 12137801
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
